📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial. (2022)

First Author: Gunst JD

Attributed to: MICA: RIVER - Recent HIV Infection Viral Eradication Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-022-02023-7

PubMed Identifier: 36253609

Publication URI: http://europepmc.org/abstract/MED/36253609

Type: Journal Article/Review

Volume: 28

Parent Publication: Nature medicine

Issue: 11

ISSN: 1078-8956